Search

Your search keyword '"Man, Wenling"' showing total 7 results
Start Over Author "Man, Wenling"
7 results on '"Man, Wenling"'

4. Clinical study of transcatheter arterial chemoembolization combined with microwave ablation in the treatment of advanced hepatocellular carcinoma

Author

Li, Wei, Man, Wenling, Guo, Huanqing, and Yang, Po

Subjects
Hepatocellular carcinoma -- Development and progression -- Care and treatment, Therapeutic chemoembolization -- Methods -- Patient outcomes, Health
Abstract

Byline: Wei. Li, Wenling. Man, Huanqing. Guo, Po. Yang Objective: To evaluate the safety and efficacy of transcatheter arterial chemoembolization (TACE) combined with percutaneous microwave ablation (MWA) in the treatment [...]

Published
2016

7. Clinical study of transcatheter arterial chemoembolization combined with microwave ablation in the treatment of advanced hepatocellular carcinoma.

Author

Wei Li, Wenling Man, Huanqing Guo, Po Yang, Li, Wei, Man, Wenling, Guo, Huanqing, and Yang, Po

Subjects
CHEMOEMBOLIZATION, LIVER cancer, INTERVENTIONAL radiology, ABLATION techniques, LIVER cancer patients, TUMOR treatment, MICROWAVES, CATHETER ablation, COMBINED modality therapy, COMPUTED tomography, HEPATOCELLULAR carcinoma, LIVER tumors, SURVIVAL analysis (Biometry), TUMOR classification, TREATMENT effectiveness, CASE-control method, THERAPEUTICS
Abstract

Objective: To evaluate the safety and efficacy of transcatheter arterial chemoembolization (TACE) combined with percutaneous microwave ablation (MWA) in the treatment of advanced hepatocellular carcinoma (HCC).Materials and Methods: Three thousand cases of advanced HCC patients were randomly divided into two groups: 1500 cases in the treatment group were treated with TACE combined with MWA and 1500 cases in the control group were treated with TACE.Results: The effective rate of the treatment group and control group was 71.4% and 42.8%, respectively, and the difference between the two groups was statistically significant (P < 0.05). During the follow-up period at 6, 12, 18, and 24 months postoperatively, the survival rates of the treatment group were 88.1%, 73.8%, 52.3%, and 33.3%, and the survival rates of the control group were 76.2%, 57.1%, 30.9%, and 9.5%, respectively. There was no significant difference in postoperative complications between the two groups.Conclusion: It is safe and effective to use TACE combined with MWA in the treatment of advanced HCC, and the effect of combined treatment is better than that of TACE alone. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results